MDB Capital Holdings
MDBH

$7.65

1.92%

Market Cap: $71.1M

About: MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

Employees: 40

Financials Finance Services

0

Funds holding %

of 6,710 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

80% more funds holding

Funds holding: 5 [Q1] → 9 (+4) [Q2]

0.59% more ownership

Funds ownership: 4.53% [Q1] → 5.11% (+0.59%) [Q2]

18% less capital invested

Capital invested by funds: $2M [Q1] → $1.64M (-$351K) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for MDBH.

See Analyst Rankings

Financial journalist opinion

MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies

Record date of July 22, 2024 set for allocation preferences Closing and trading expected on NASDAQ on or before August 15 Addison, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today announces the record date, allocation preference, and expected timeline for the proposed offering for Invizyne Technologies, Inc. In February 2024, Invizyne – a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life and a subsidiary of MDB Capital Holdings – filed its IPO registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") for the sale of its common stock in a firm commitment public offering. The offering will be for 4,300,000 shares of common stock at a price per share of $4.00, for gross proceeds of $17.2 million.

MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies

Recently Published Whitepaper from PatentVest Delves into Transformative Innovations in MASH Diagnostics

Transformative Innovations in MASH Diagnostics Dallas, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- PatentVest, the first integrated IP intelligence strategy and law firm, recently published a whitepaper that presents strategic insights in the fields of Metabolic-Associated Steatohepatitis (MASH) biomarkers and Point of Care (PoC) kits for MASH diagnostics. This whitepaper serves as a valuable resource for stakeholders looking to navigate the complex and rapidly evolving landscape of these fields, offering guidance on capitalizing on innovation, collaboration, and IP protection to gain a competitive edge.

Recently Published Whitepaper from PatentVest Delves into Transformative Innovations in MASH Diagnostics

MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform

ADDISON, Texas, July 08, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today announced a collaboration through a patent and know-how agreement with Mayo Clinic to develop a small molecule anti-senescence platform. This collaboration aims to advance research in longevity and age-related disease prevention.

MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform

MDB Capital Expands Board, Appoints Daniel Torpey as New Director

Addison, Texas, June 20, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB Capital”), a public venture platform focused on launching category-leading deep technology companies, today announced the appointment of Daniel Torpey to its Board of Directors, effective June 17, 2024.

MDB Capital Expands Board, Appoints Daniel Torpey as New Director

New PatentVest Pulse Report Reveals Transformative Trends in Portable ECG Monitoring

56% increase in global patent publications over the last five years signals growing interest in the cardiac monitoring market which is expected to grow to $3 billion per year by 2029 according to Statista. PatentVest's report provides groundbreaking insights into the evolving landscape of cardiac care, highlighting key players, technological advancements and the race for innovation.

New PatentVest Pulse Report Reveals Transformative Trends in Portable ECG Monitoring

MDB Capital Holdings Unveils Unified Corporate Branding

Addison, TX, May 22, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today announces its self-clearing broker dealer and associated online and mobile trading platforms will now unify under one brand name, MDB Capital.

MDB Capital Holdings Unveils Unified Corporate Branding

Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq

Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exits Additional industry veterans join in key roles including business development, finance, and communications MONROVIA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc. , a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, today announced the appointment of Michael Heltzen as CEO, and the recent hirings of additional seasoned industry executives for its leadership team.

Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq

Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq

MONROVIA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc. , a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, today announced the appointment of Michael Heltzen as CEO, and the recent hirings of additional seasoned industry executives for its leadership team.

Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq

MDB Capital Holdings Year-End Update

Addison, Texas, April 17, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, reported results for its fourth quarter and full year ended December 31, 2023, on form 10-K filed with the Securities and Exchange Commission, and will highlight recent corporate progress on today's call with management. “On the heels of completing our IPO on the NASDAQ in the third quarter of 2023, we've been working diligently to advance our self-clearing broker dealer capabilities to support our investor community, increasing the number of deep technology ideas we review and ultimately finance, as well as ramp up the number of clients engaged with our integrated IP solution platform, PatentVest, which is critical in assisting the companies we back to become leaders in their technology category,” said Christopher Marlett, CEO and Co-Founder of MDB.

MDB Capital Holdings Year-End Update

MDB Capital Holdings to Host Fourth Quarter 2023 and Fiscal Year 2023 Results Webinar on Wednesday April 17, 2024 at 4:30 PM Eastern Time

Addison, Texas, April 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, plans to host a Zoom webinar on Wednesday April 17, 2024 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full fiscal year ended December 31, 2023. A press release detailing these results will be issued prior to the call.

MDB Capital Holdings to Host Fourth Quarter 2023 and Fiscal Year 2023 Results Webinar on Wednesday April 17, 2024 at 4:30 PM Eastern Time

See News Rankings